IBEX Limited (IBEX)

The most compelling signal here is the convergence of a massive one-year recovery and a robust balance sheet, making this a classic 'value trap' resolution play rather than a deteriorating business. After a brutal 2024, the company staged a spectacular 76% rebound in 2025, bringing the four-year cumulative return to +37%. This isn't just a bounce; it's a structural re-rating driven by sustained 17% revenue growth and a 33% return on equity, which places it in the top tier of capital efficiency for its sector. The short-term outlook is constructive. The stock has recently reclaimed its 200-day moving average, and the options market is screaming bullishness, with traders loading up on deep out-of-the-money calls while ignoring downside protection. This asymmetry suggests smart money expects a continuation of the upward trend toward the analyst mean target of $37.50. However, investors must ignore the dividend entirely; there is no payout history, so this is purely a growth and capital appreciation vehicle. The only caution is the modest statistical forecast signal, which hints at potential short-term noise, but given the strength of the fundamentals and the aggressive options positioning, that noise likely won't derail the multi-year thesis. This is a high-conviction buy for investors seeking exposure to a turnaround story that has already proven its resilience.